Hansa Biopharma announces reimbursement in the Netherlands
-
Hansa Biopharma AB: Hansa Biopharma announces reimbursement in the Netherlands of Idefirix[
] (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients https://investors.hansabiopharma.com/English/press-releases/press-releases-details/2021/Hansa-Biopharma-announces-reimbursement-in-the-Netherlands-of-Idefirix-imlifidase-as-desensitization-treatment-for-highly-sensitized-kidney-transplant-patients/default.aspx
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind